Ardelyx (ARDX) Other Non-Current Assets (2013 - 2026)
Ardelyx (ARDX) posted Other Non-Current Assets of $6.7 million for Q1 2026, down 3.63% on a QoQ basis from $6.9 million in Q4 2025, and down 2.02% year-over-year from $6.8 million in Q1 2025.
Ardelyx (ARDX) Other Non-Current Assets (2013 - 2026) Analysis & Trends
Ardelyx's Other Non-Current Assets history runs 14 years deep, the most recent figure standing at $6.7 million for Q1 2026.
- Quarterly Other Non-Current Assets fell 2.02% year-over-year to $6.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.7 million (down 2.02% YoY) and the FY2025 annual result came in at $6.9 million, up 28.06% from the prior year.
- Other Non-Current Assets was $6.7 million for Q1 2026 at Ardelyx, down from $6.9 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $13.3 million in Q3 2022 and bottomed at $673000.0 in Q2 2023.
- A 5-year average of $4.9 million and a median of $5.4 million in 2024 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets soared 976.01% — and 2023, when it tumbled 88.36%.
- Ardelyx's Other Non-Current Assets stood at $881000.0 in 2022, then soared by 308.17% to $3.6 million in 2023, then soared by 50.61% to $5.4 million in 2024, then advanced by 28.06% to $6.9 million in 2025, then slipped by 3.63% to $6.7 million in 2026.
- Business Quant data shows ARDX's Other Non-Current Assets at $6.7 million in Q1 2026, $6.9 million in Q4 2025, and $6.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Ardelyx | 1.26 Bn | 1.02 Bn | 89.66 Mn | 6.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.68 Mn |
| Dec 31, 2025 | 6.94 Mn |
| Sep 30, 2025 | 6.78 Mn |
| Jun 30, 2025 | 7.07 Mn |
| Mar 31, 2025 | 6.82 Mn |
| Dec 31, 2024 | 5.42 Mn |
| Sep 30, 2024 | 5.33 Mn |
| Jun 30, 2024 | 5.45 Mn |
| Mar 31, 2024 | 5.50 Mn |
| Dec 31, 2023 | 3.60 Mn |
| Sep 30, 2023 | 1.55 Mn |
| Jun 30, 2023 | 673,000.00 |
| Mar 31, 2023 | 774,000.00 |
| Dec 31, 2022 | 881,000.00 |
| Sep 30, 2022 | 13.32 Mn |
| Jun 30, 2022 | 4.91 Mn |
| Mar 31, 2022 | 1.23 Mn |
| Dec 31, 2021 | 1.15 Mn |
| Sep 30, 2021 | 1.24 Mn |
| Jun 30, 2021 | 1.31 Mn |